The largest community of pharma leaders

Excalibur Rapid SARS-COV-2 Antigen Screening Test Granted MHRA Approval for Mass Population Screening for COVID-19 in Asymptomatic and Symptomatic People

LONDON–(BUSINESS WIRE)–Excalibur Healthcare Services Ltd, a leading UK-based provider of high-quality medical products and services, has announced that its Rapid SARS COV-2 Antigen Screening test is the first ever lateral flow antigen test to receive regulatory approval for use in mass screening for COVID-19 in asymptomatic, pre-symptomatic and symptomatic populations. To date, COVID-19 tests in the UK have been approved for use only on people displaying COVID-19 symptoms. Now, following appr

Source Business Wire Health: Pharmaceutical NewsRead More

Recent Articles